ATE82496T1 - Vesikelformulierungen zur kontrollierten abgabe der wirkstoffe. - Google Patents

Vesikelformulierungen zur kontrollierten abgabe der wirkstoffe.

Info

Publication number
ATE82496T1
ATE82496T1 AT84303092T AT84303092T ATE82496T1 AT E82496 T1 ATE82496 T1 AT E82496T1 AT 84303092 T AT84303092 T AT 84303092T AT 84303092 T AT84303092 T AT 84303092T AT E82496 T1 ATE82496 T1 AT E82496T1
Authority
AT
Austria
Prior art keywords
active ingredients
controlled release
vesicle formulations
solution
therapeutic agent
Prior art date
Application number
AT84303092T
Other languages
English (en)
Inventor
Richard A Callahan
George Wing-Yiu Tin
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Application granted granted Critical
Publication of ATE82496T1 publication Critical patent/ATE82496T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT84303092T 1983-05-06 1984-05-08 Vesikelformulierungen zur kontrollierten abgabe der wirkstoffe. ATE82496T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49249783A 1983-05-06 1983-05-06
US60645084A 1984-05-02 1984-05-02
EP84303092A EP0126580B1 (de) 1983-05-06 1984-05-08 Vesikelformulierungen zur kontrollierten Abgabe der Wirkstoffe

Publications (1)

Publication Number Publication Date
ATE82496T1 true ATE82496T1 (de) 1992-12-15

Family

ID=27050770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84303092T ATE82496T1 (de) 1983-05-06 1984-05-08 Vesikelformulierungen zur kontrollierten abgabe der wirkstoffe.

Country Status (4)

Country Link
EP (1) EP0126580B1 (de)
JP (1) JPH0768117B2 (de)
AT (1) ATE82496T1 (de)
DE (1) DE3485984T2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0764721B2 (ja) * 1985-11-22 1995-07-12 武田薬品工業株式会社 リポソ−ム製剤
ES2039203T3 (es) * 1985-11-22 1993-09-16 Takeda Chemical Industries, Ltd. Composicion de liposomas.
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
JP2599390B2 (ja) * 1987-06-25 1997-04-09 第一製薬株式会社 安定なリポソーム水分散液
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
DE68901733T2 (de) * 1988-03-04 1993-03-25 Takeda Chemical Industries Ltd Liposom-zusammensetzung.
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
EP2198854B1 (de) 1997-09-18 2011-11-30 Pacira Pharmaceuticals, Inc. Retardierte Freisetzung Liposomaler Anesthetischer Zusammensetzungen
ATE554748T1 (de) 1997-11-14 2012-05-15 Pacira Pharmaceuticals Inc Herstellung von multivesikulären liposomen
DE10214983A1 (de) 2002-04-04 2004-04-08 TransMIT Gesellschaft für Technologietransfer mbH Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
DE102009031274A1 (de) 2009-06-30 2011-01-13 Justus-Liebig-Universität Giessen Liposomen zur pulmonalen Applikation
US9427186B2 (en) 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
US10634741B2 (en) 2009-12-04 2020-04-28 Endomagnetics Ltd. Magnetic probe apparatus
CN105283202B (zh) 2013-03-11 2019-04-23 安都磁学有限公司 用于淋巴结检测的低渗溶液
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
EP3782575A1 (de) 2015-06-04 2021-02-24 Endomagnetics Ltd. Markermaterialien und -formen zur lokalisierung magnetischer marker
US10532046B2 (en) * 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
SG10202107836SA (en) * 2017-01-18 2021-08-30 Temasek Life Sciences Laboratory Ltd Hyperstabilized liposomes increase targeting of mitotic cells
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
EP4415713A4 (de) 2021-10-14 2025-08-06 Pacira Pharmaceuticals Inc Bupivacain-multivesikuläre liposomformulierungen und verwendungen davon
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
JPS5841814A (ja) * 1981-08-10 1983-03-11 ザ・ウエルカム・フアウンデ−シヨン・リミテツド 抗レ−シユマニア症薬剤組成物およびその製造法

Also Published As

Publication number Publication date
JPH0768117B2 (ja) 1995-07-26
EP0126580B1 (de) 1992-11-19
DE3485984T2 (de) 1993-03-25
EP0126580A3 (en) 1985-03-06
EP0126580A2 (de) 1984-11-28
DE3485984D1 (de) 1992-12-24
JPS6127918A (ja) 1986-02-07

Similar Documents

Publication Publication Date Title
ATE82496T1 (de) Vesikelformulierungen zur kontrollierten abgabe der wirkstoffe.
EP0280492A3 (en) Liposome composition and its production
DE3855265D1 (de) Liposomen-Formulierungen mit hohem antineoplastischem Wirkstoff/Lipid-Verhältnis
MX162898B (es) Metodo para preparar una composicion para entregar una cantidad de una dosis constante de un ingrediente activo a un animal
DK0395329T3 (da) Sammensætning i form af et skum indeholdende 5-aminosalicylsyre til intrarektal administration
DK0454832T3 (da) Polyvinylacetat-indkapsling af samtørret sucralose til anvendelse i tyggegummi
ATE152614T1 (de) Mittel zur behandlung entzündeter gewebe
IL89602A0 (en) Compositions containing bioactive agents and methods for the preparation thereof
IL73318A0 (en) Medicament formulation for intravenous injection and its preparation
SE8402560L (sv) Farmaceutisk komposition
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
FI886019A7 (fi) Laastari vaikuttavien aineiden valvotusti jakamiseksi iholle
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
ATE113470T1 (de) Gehirnspezifische zubereitung mit gesteuerter abgabe.
IT1169772B (it) Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina
SE8400723D0 (sv) Farmaceutisk komposition
ZA871654B (en) Method and compositions for increasing mammary parenchyma
DK78487A (da) Farmaceutisk praeparat indeholdende et i vand kvaeldende polymermateriale
ES459244A1 (es) Un procedimiento para la fabricacion de preparados oftalmi- cos de emision lenta
EP1103269A4 (de) Herstellungen zur verabreichung des hepatozyten wachstumsfaktor
ES449874A1 (es) Procedimiento para la obtencion de un agente para el trata- miento de la mistitis bovina.
FR2549835B1 (fr) Acides peneme-carboxyliques, leur preparation et leur utilisation therapeutique, notamment en tant qu'agents antibacteriens
IL93721A0 (en) Mixed micelles compositions and their use as carriers for the parenteral application of the drugs
IT1186775B (it) Derivati nuobosidici aventi proprieta' antierpetiche,composizioni farmaceutiche che li contengono e procedimento per la preparazione degli ingredienti attivi
JPS53101383A (en) Isocarbostyryl derivatives and their preparation

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time